🇺🇸 FDA

Company profile · Sponsor

Italfarmaco

Italfarmaco S.p.A.

EC6E83F · EMA pharma EU
Pipeline
7
Drugs
0
Patents
0

Quick answer

Italfarmaco (EC6E83F) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EC6E83F
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (7)

Search pipeline →

  1. Givinostat 50 mg capsules, RIVAROXABAN , ACETYLSALICYLIC ACID , Givinostat 100 mg capsules, HYDROXYCARBAMIDE, ENOXAPARIN , -, Givinostat 75 mg capsules, DABIGATRAN ETEXILATE

    Italfarmaco

    JAK2V617F-positive high-risk Polycythemia Vera

    phase 3 small molecule active

    1 trial

  2. ITF2357

    Italfarmaco

    Duchenne Muscular Dystrophy (DMD)

    phase 3 small molecule active

    1 trial

  3. PLACEBO for GIVINOSTAT hydrochloride monohydrate (ITF2357) 10 mg/mL oral suspension, ITF2357

    Italfarmaco

    Duchenne muscular dystrophy (DMD)

    phase 3 small molecule active

    1 trial

  4. Givinostat 75 mg capsules, Givinostat 100 mg capsules, Givinostat 50 mg capsules

    Italfarmaco

    Chronic myeloproliferative neoplasm

    phase 2 small molecule active

    1 trial

  5. ITF2357

    Italfarmaco

    Duchenne muscular dystrophy (DMD)

    phase 2 small molecule active

    1 trial

  6. A multicentric, open-label, non-randomized study to evaluate the pharmacokinetic, safety and tolerability of ITF2357 given as an oral single 50 mg dose in participants with chronic hepatic impairment relative to matched participants with normal hepatic function.

    Italfarmaco

    Participants with normal hepatic function, Participants with moderate HI, Participants with mild HI

    phase 1 other active

    1 trial

  7. EFFIMIA 0,250 mg/0,035mg, Compresse

    Italfarmaco

    Female contraception.

    approved small molecule active

    1 trial

Frequently asked questions

What is Italfarmaco?

Italfarmaco (EC6E83F) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Italfarmaco sponsor?

We track 7 ClinicalTrials.gov-linked programs for Italfarmaco, including Givinostat 50 mg capsules, RIVAROXABAN , ACETYLSALICYLIC ACID , Givinostat 100 mg capsules, HYDROXYCARBAMIDE, ENOXAPARIN , -, Givinostat 75 mg capsules, DABIGATRAN ETEXILATE and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Italfarmaco company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.